← 返回

增强子驱动的基因调控网络揭示调控肿瘤微环境中 T 细胞适应与分化的转录因子

英文原题:Enhancer-driven gene regulatory networks reveal transcription factors governing T cell adaptation and differentiation in the tumor microenvironment.

查看英文原题

Enhancer-driven gene regulatory networks reveal transcription factors governing T cell adaptation and differentiation in the tumor microenvironment.

PubMed 2025/05/26(内容时间) Immunity Q1 · IF 30.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

组织驻留记忆CD8+ T细胞(Trm)表型的TIL(肿瘤浸润淋巴细胞)与实体瘤患者结局改善相关。为界定调控Trm样TIL形成的程序,我们在感染和癌症模型中,对TCR匹配的CD8+ T细胞进行配对单细胞RNA测序和单细胞ATAC测序。基于多组学分析数据构建的增强子驱动调控子,揭示了调控Trm样TIL形成的表观遗传及转录程序,并将其与经典耗竭和记忆T细胞状态关联起来。转录调节因子KLF2抑制CD69+ CD103+ Trm样TIL形成,并限制抗肿瘤活性。相反,持续表达转录因子BATF可增强CD69+ CD103+ TIL形成,但这一作用取决于KLF2下调。转化生长因子(TGF-β)信号和CD103表达是Trm样TIL形成所必需的,但在TGFBR2沉默细胞中,过表达BATF足以驱动CD69+ CD103+ TIL形成。这些发现揭示了Trm样TIL分化机制,并为结合肿瘤微环境中CD8+ T细胞异质性考察组织驻留提供了框架。

展开英文摘要原文

Tumor-infiltrating lymphocytes (TILs) with a tissue-resident memory CD8 + T cell (Trm) phenotype are associated with improved patient outcomes in solid malignancies. To define programs governing the formation of Trm-like TIL, we performed paired single-cell RNA sequencing and single-cell ATAC sequencing of T cell receptor (TCR)-matched CD8 + T cells in models of infection and cancer. Enhancer-driven regulons assembled from multiomic profiling data revealed epigenetic and transcriptional programs regulating the formation of Trm-like TIL in relation to canonical exhausted and memory T cell states.

The transcriptional regulator KLF2 repressed the formation of CD69 + CD103 + Trm-like TIL and limited anti-tumor activity. Conversely, sustained expression of the transcription factor BATF enhanced formation of CD69 + CD103 + TIL, contingent upon downregulation of KLF2. Transforming growth factor (TGF- ) signaling and CD103 expression were necessary for Trm-like TIL formation, but BATF overexpression was sufficient to drive formation of CD69 + CD103 + TIL in TGFBR2-silenced cells.

These findings reveal mechanisms of Trm-like TIL differentiation and provide a framework for considering tissue residency in the context of CD8 + T cell heterogeneity in the tumor microenvironment.

论文信息

作者
Green WD、Gomez A、Plotkin AL、Pratt BM、Merritt EF、Mullins GN、Kren NP、Modliszewski JL
第一作者单位
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.United States
通讯作者单位
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: justin_milner@med.unc.edu.United States
期刊
Immunity2025 Jul 8
原文标识
PubMed 40425012 · DOI 10.1016/j.immuni.2025.04.030